BioSpace News Archive

Deals

Viking Therapeutics to Participate in Upcoming Investor Conferences and Events

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced that the company will participate in four upcoming investor conferences and events.

February 26, 2019

·

2 min read

Business

ImaginAb Announces change in management and strengthening of the Board of Directors and the Scientific Advisory Board

ImaginAb, Inc., a clinical stage immuno-oncology imaging company, announced the appointment of Ian Wilson as Chief Executive Officer while Martyn Coombs steps down for family reasons, effective immediately.

February 26, 2019

·

3 min read

Policy

Celgene Corporation Announces Key Regulatory Updates for REVLIMID® in Lymphoma and Luspatercept in MDS and Beta-Thalassemia

U.S. FDA grants Priority Review for REVLIMID® (lenalidomide) in combination with rituximab (R²) for previously treated follicular and marginal zone lymphoma

February 26, 2019

·

19 min read

Business

Delray Center for Healing First in Florida to Treat Patients Suffering From Obsessive-Compulsive Disorder (OCD) with Deep Transcranial Magnetic Stimulation (Deep TMS)

Delray Center for Healing, a leading provider of mental health services in the United States, announced today that it is offering BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for Obsessive-Compulsive Disorder (OCD) at its facility in Delray Beach, Florida.

February 26, 2019

·

3 min read

Pharm Country

“Silent-type” Cells Play Greater Role in Brain Behavior than Previously Thought

Brain cells recorded as among the least electrically active during a specific task may be the most important to doing it right.

February 26, 2019

·

3 min read

Liht Cannabis Corp. Provides Shareholders Update On Harvest - Las Vegas, Nevada

Liht Cannabis Corp. provides an “in-progress” update on the Company’s first harvest in Las Vegas, Nevada.

February 26, 2019

·

7 min read

Pharm Country

Carnegie Learning Given Level 1 ‘Strong’ Rating by Johns Hopkins University’s Evidence for ESSA Initiative

Carnegie Learning announced today that the Carnegie Learning Math Solution meets U.S. Department of Education standards under the Every Student Succeeds Act (ESSA) as a Level 1 program demonstrating “Strong Evidence” of efficacy.

February 26, 2019

·

4 min read

Business

Personal Genome Diagnostics Appoints Jack Crowley as Chief Financial Officer

Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, announced that Jack Crowley has joined the company as Chief Financial Officer.

February 26, 2019

·

2 min read

FDA

ROMEG Therapeutics Receives FDA Approval of GLOPERBA® (colchicine) for Prophylaxis of Adult Gout Flares

ROMEG Therapeutics, an innovative drug development company focused on alternative formulations to better meet clinical and patient needs, today announced that the U.S. Food and Drug Administration (FDA) approved GLOPERBA

February 26, 2019

·

2 min read

Pharm Country

Henry Schein, Inc. Named One Of The 2019 World’s Most Ethical Companies® By Ethisphere

Recognition honors those companies who recognize their critical role to influence and drive positive change in the business community and societies around the world.

February 26, 2019

·

4 min read